✦ LIBER ✦

PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats

✍ Scribed by Aina Rodríguez-Vilarrupla; Bàrbara Laviña; Héctor García-Calderó; Lucia Russo; Eugenio Rosado; Núria Roglans; Jaume Bosch; Joan Carles García-Pagán

Book ID: 116652685
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 941 KB
Volume: 56
Category: Article
ISSN: 0168-8278
DOI: 10.1016/j.jhep.2011.12.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

20 PPARα ACTIVATION REDUCES PORTAL PRESS

20 PPARα ACTIVATION REDUCES PORTAL PRESSURE AND AMELIORATES ENDOTHELIAL DYSFUNCTION IN CIRRHOSIS

✍ A. Rodriguez-Vilarrupla; B. Lavina; H. García-Calderó; L. Russo; M. Fernández; J 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Low dose losartan reduces portal pressur

Low dose losartan reduces portal pressure, improves kidney function and vascular contractility in cirrhotic rats without affecting arterial pressure

✍ Joerg Heller; Jonel Trebicka; Thomas Shiozawa; Michael Schepke; Markus Neef; Til 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 326 KB

[118] EXTRACELLULAR SUPEROXIDE DISMUTASE

[118] EXTRACELLULAR SUPEROXIDE DISMUTASE GENE TRANSFER REDUCES PORTAL PRESSURE AND IMPROVES INTRAHEPATIC ENDOTHELIAL DYSFUNCTION IN CIRRHOTIC RAT LIVERS BY DIMINISHING SUPEROXIDE AND INCREASING NITRIC OXIDE BIOAVAILABILITY

✍ B. Lavina; J. Gracia-Sancho; A. Rodriguez-Vilarrupla; Y. Chu; D.D. Heistad; J. B 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 288 KB

Atorvastatin lowers portal pressure in c

Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase

✍ Jonel Trebicka; Martin Hennenberg; Wim Laleman; Nataliya Shelest; Erwin Biecker; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 685 KB

In cirrhosis, increased RhoA/Rho-kinase signaling and decreased nitric oxide (NO) availability contribute to increased intrahepatic resistance and portal hypertension. Hepatic stellate cells (HSCs) regulate intrahepatic resistance. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins)

Three-day tetrahydrobiopterin therapy in

Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats

✍ Vasilica Matei; Aina Rodríguez-Vilarrupla; Ramon Deulofeu; Héctor García-Calderó 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 322 KB

High-density lipoprotein administration

High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats

✍ Dominique Thabut; Khalid A. Tazi; Dominique Bonnefont-Rousselot; Maria Aller; Ol 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 781 KB

In patients with cirrhosis, endotoxic shock is a major complication of portal hypertension, which is related partly to intrahepatic endothelial nitric oxide synthase (eNOS) down-regulation. High-density lipoproteins (HDLs), whose plasma levels are reduced in cirrhosis, have an anti-inflammatory effe